Characteristic | |
---|---|
No. of patients | 16 |
Sex M:F | 12:4 |
BVAS, mean (range) | 22.1 (12–34) |
cANCA-positive % | 100 |
PR-3, mean (range) U/ml | 13.1 (0–98) |
CRP, mean (range) mg/l | 6.23 (3.0–16.5) |
Disease duration, median (range) yrs | 5.6 (1–12) |
Therapy | |
Corticosteroids | 16 |
Azathioprine | 7 |
Methotrexate | 6 |
Cyclophosphamide | 3 |
BVAS: Birmingham Vasculitis Activity Score27; cANCA: antineutrophil cytoplasmic antibody (central); PR-3: proteinase-3 antigen; CRP: C-reactive protein.